相关实验视频
Updated: Sep 14, 2025

07:56
Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
Published on: August 18, 2010
13.6K
开发一个模块化核糖蛋白复合体作为提供RNAi治疗的总体策略
Nok Yin Tam1, Xiaoqi Wang2, Grace Chung Yan Chan1,2
1Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Kowloon, Hong Kong SAR, China.
Advanced healthcare materials
|July 24, 2025
概括
研究人员开发了一个新的RNAi传递平台,使用重塑的核糖蛋白复合体 (SmiRNP). 这种SmiRNP系统有效地提供小干扰RNA (siRNA) 来减少KRAS,抑制瘤生长,并为RNAi治疗提供了一种多功能策略.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 药物运输 药物运输 药物运输
背景情况:
- RNAi疗法为治疗目前被认为是无法治疗的疾病提供了潜力.
- 在RNAi治疗开发中的重大挑战与高效和安全的输送系统有关.
- 现有的传递方法通常面临生物相容性,模块化和定制性的局限性.
研究的目的:
- 开发一种新的,生物相容的,模块化平台,用于提供小干扰RNA (siRNA) 疗法.
- 克服当前RNAi传递系统的局限性.
- 在临床前癌症模型中证明开发平台的有效性.
主要方法:
- 重塑人类的U4小核核核糖核蛋白复合体 (snRNP) 以创建一个蛋白质-siRNA复合体 (SmiRNP).
- 使用siRNA针对KRAS作为SmiRNP平台的原则证明.
- 评估SmiRNP复合体将siRNA输送到细胞中的能力,防止核酶降解,并在体外和体内实现目标敲击.
主要成果:
- 该SmiRNP复合物成功地将siRNA输入细胞,保护其免受降解.
- 显著降低了KRAS mRNA和蛋白质水平.
- 在体内观察到癌细胞活力下降和瘤生长抑制.
结论:
- 该SmiRNP平台提供了一个生物相容,模块化和可定制的RNAi交付方法.
- 这一战略有效地克服了RNAi疗法的关键交付障碍.
- SmiRNP系统有望为各种疾病提供广泛的基于RNAi的治疗方案.
相关概念视频
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Types of RNA
64.9K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.9K
MicroRNAs
21.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.8K
Small interfering RNAs (siRNA)
3.6K
3.6K

